Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?

Cardiovascular Drug Reviews
M E CooperM de Gasparo

Abstract

This review deals with similarities and differences between the effects of ACE inhibitors and AT1-receptor blockers in the kidney. Specific receptor blockade has demonstrated that the beneficial effects of AT1 blockers arise from two mechanisms: the reduction of the AT1 receptor mediated response and the increase in plasma levels of Ang II through the AT1-receptor blockade, which leads to increased stimulation of the AT2 receptor (the so-called yin-yang effect). Both ACE inhibition and AT1-receptor blockade provide significant renal protection in the majority of experimental animal models of kidney diseases. AT1 receptor blockade may offer additional clinical benefits over ACE inhibitor treatment, particularly in the kidney, where AT1-receptor blockade does not cause the fall in glomerular filtration rate seen with ACE inhibitor treatment. A number of long-term clinical studies currently running should show the real value of this new class of compounds in the management of hypertension and associated cardiorenal diseases.

References

Sep 1, 1992·The Journal of Clinical Investigation·R A LafayetteT W Meyer
Jul 1, 1992·American Journal of Hypertension·A L KamperP P Leyssac
Mar 1, 1995·The Journal of Clinical Investigation·M LoJ Sassard
Jan 1, 1994·The Journal of Urology·D A GoldfarbA C Novick
Jul 1, 1993·Journal of the American Society of Nephrology : JASN·A RemuzziG Remuzzi
Jun 1, 1996·Kidney International·M BurnierH R Brunner
Apr 1, 1996·Journal of Cardiovascular Pharmacology·P LantelmeJ Sassard
Aug 1, 1996·Journal of Cardiovascular Pharmacology·J P FauvelM Laville
Jun 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R A Rodby
Jul 15, 1997·The Journal of Clinical Investigation·H M Siragy, R M Carey
Apr 2, 1998·Experimental Nephrology·A RemuzziG Remuzzi
Sep 30, 1998·American Journal of Hypertension·A WynckelJ Chanard
Oct 9, 1998·Clinical and Experimental Hypertension : CHE·R L WebbP Sahota
Oct 17, 1998·Journal of the American Society of Nephrology : JASN·S C AmuchasteguiG Remuzzi
Jan 8, 1999·Regulatory Peptides·P P SayeskiK E Bernstein
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·H M SiragyR M Carey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.